-
GSTA1 in α-Amanitin Hepatotoxicity
2026-08-25
The reference study identifies GSTA1 as an unexpected driver of α-amanitin liver injury rather than a purely protective detoxification enzyme. By combining mouse toxicology, multi-omics, molecular interaction assays, and genetic rescue experiments, it links NRF2-associated GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte death.
-
Uridine, Trisodium Salt in Cell Assays
2026-08-25
Learn how Uridine, Trisodium Salt (SKU B1473) can be incorporated into cell viability, proliferation, cytotoxicity, and RNA metabolism studies without obscuring assay interpretation. This scenario-driven guide covers controls, solubility, stock preparation, storage, data analysis, and practical supplier selection.
-
Exercise, Muscle EVs, and Microglial Aβ Clearance
2026-08-24
A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as mediators of exercise-related benefits in Alzheimer’s disease mice. The work links swimming-induced vesicle release to microglial plaque clearance and implicates miR-378a-3p–dependent lipid-metabolism regulation as a potential exercise-mimicking therapeutic mechanism.
-
Z-WEHD-FMK for Caspase-1 Pathway Studies
2026-08-24
Z-WEHD-FMK enables time-controlled inhibition of inflammatory caspases in pyroptosis, cancer-cell signaling, and pathogen-inclusion models. This practical guide connects the HOXC8–caspase-1 findings in lung cancer with dose planning, orthogonal readouts, and troubleshooting for inflammation research and infectious disease research.
-
VX-765: A Mechanistic Guide to Pyroptosis Assays
2026-08-23
VX-765 and its active metabolite VRT-043198 provide a focused way to test caspase-1-dependent inflammation and pyroptosis. This guide translates endothelial oxidative-stress research into practical assay design, interpretation, and cross-model decision-making.
-
Cabozantinib (XL184) RCC Workflow Guide
2026-08-22
Cabozantinib (XL184) supports more than short-term kinase inhibition: it enables paired acute and chronic renal cell carcinoma experiments that reveal time-dependent signaling adaptation. This workflow combines phosphoproteomics, site-specific validation, angiogenesis assays, and motility testing while emphasizing solvent control and interpretation of chronic exposure data.
-
SLC11A1–TGF-β1 Signaling in Colorectal Cancer
2026-08-21
Yang and colleagues identify SLC11A1 as a colorectal cancer-associated factor that promotes proliferation, migration, and invasion while reducing cellular susceptibility to ferroptosis. Their data connect SLC11A1 with TGF-β1/Smad2/3 signaling and provide a mechanistic basis for studying ferroptosis resistance, although further rescue and in vivo experiments are needed to establish therapeutic relevance.
-
Calpeptin Workflows for Fibrosis and EV Research
2026-08-20
Calpeptin is a nanomolar calpain inhibitor for dissecting calcium-dependent proteolysis in fibroblast activation, inflammatory signaling, and extracellular-vesicle biology. This guide connects fibrosis assays with an orthogonal EV-release workflow while emphasizing controls, solvent handling, normalization, and interpretation limits.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-08-20
Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris both damages host cells and actively enters them through clathrin-mediated endocytosis and macropinocytosis. The study combines pharmacological inhibition, cytoskeletal perturbation, microscopy, and intracellular bacterial quantification to define an entry process relevant to invertebrate infection biology.
-
S63845: MCL1 Dependency in Translational Apoptosis
2026-08-19
S63845 provides a selective way to interrogate MCL1 dependency, mitochondrial apoptosis, and residual disease biology. This thought-leadership perspective connects mechanistic evidence from chemotherapy-induced senescence with practical assay design and translational strategy in hematological cancer research.
-
Pravastatin sodium: Assay Workflows and Optimization
2026-08-19
Build reproducible cholesterol, macrophage, and hepatocyte assays with Pravastatin sodium, an HMG-CoA reductase inhibitor suited to concentration-response and transporter-aware study designs. The workflow combines pathway-specific readouts with viability controls to distinguish cholesterol biosynthesis inhibition from nonspecific cellular stress.
-
Dual Metabolic Reprogramming in TNBC Ferroptosis
2026-08-18
The reference study identifies a previously overlooked trade-off in brequinar-mediated ferroptosis: DHODH inhibition can sensitize tumor cells to oxidative death while increasing lipid-droplet accumulation that reinforces resistance. Its AB@HA-TA/Fe nanoplatform co-delivers brequinar and the DGAT1 inhibitor A922500, producing dual metabolic intervention and antitumor activity in 4T1 models in vitro and in vivo.
-
Self-Amplifying RNA for Dose-Sparing Influenza Vaccines
2026-08-18
This study directly compares nucleoside-modified mRNA, self-amplifying RNA, and circular RNA vaccines across seasonal influenza subtypes. Its central finding is that a low-dose trivalent self-amplifying RNA formulation overcame the weak influenza B response observed with conventional mRNA and produced durable protection in mice.
-
From ROS Signal to Mechanism: DCFH-DA in PCOS
2026-08-17
A translational framework for using 2,7-Dichlorodihydrofluorescein diacetate and DCFH-DA to connect oxidative-stress measurements with granulosa-cell biology, pathway validation, and therapeutic decision-making in PCOS research.
-
FPH1 (BRD-6125) Hepatocyte Workflow Guide
2026-08-17
FPH1 (BRD-6125) supports a practical route to expanding functional human hepatocytes while tracking proliferation and liver-specific performance in parallel. This guide connects primary human hepatocyte culture and iPS-derived hepatocyte workflows with quantitative readouts, compound-handling controls, and a carefully bounded perspective on optogenetic gene-regulation research.